Your browser doesn't support javascript.
loading
Effects of Complement Regulators and Chemokine Receptors in Type 2 Diabetes.
Aydin Ozgur, B; Coskunpinar, E; Bilgic Gazioglu, S; Yilmaz, A; Musteri Oltulu, Y; Cakmakoglu, B; Deniz, G; Gurol, A O; Yilmaz, M T.
Afiliación
  • Aydin Ozgur B; Department of Immunology, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey.
  • Coskunpinar E; Department of Medical Biology and Genetics, Faculty of Medicine, Demiroglu Bilim University, Istanbul, Turkey.
  • Bilgic Gazioglu S; Department of Medical Biology, Faculty of Medicine, Health Science University, Istanbul, Turkey.
  • Yilmaz A; Department of Immunology, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey.
  • Musteri Oltulu Y; Department of Immunology, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey.
  • Cakmakoglu B; Department of Medical Biology, Faculty of Medicine, Biruni University, Istanbul, Turkey.
  • Deniz G; Department of Molecular Medicine, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey.
  • Gurol AO; Department of Immunology, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey.
  • Yilmaz MT; Department of Immunology, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey.
Immunol Invest ; 50(5): 478-491, 2021 Jul.
Article en En | MEDLINE | ID: mdl-32611246

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Antígenos CD59 / Antígenos CD55 / Receptores CXCR4 / Diabetes Mellitus Tipo 2 / Quimiocina CXCL12 / Genotipo Tipo de estudio: Prognostic_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Immunol Invest Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Turquía Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Antígenos CD59 / Antígenos CD55 / Receptores CXCR4 / Diabetes Mellitus Tipo 2 / Quimiocina CXCL12 / Genotipo Tipo de estudio: Prognostic_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Immunol Invest Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Turquía Pais de publicación: Reino Unido